Annual Reports

 
Quarterly Reports

 
8-K

  • 8-K (Nov 5, 2009)
  • 8-K (Aug 10, 2009)
  • 8-K (Aug 6, 2009)
  • 8-K (Jun 9, 2009)
  • 8-K (Jun 5, 2009)
  • 8-K (Jun 4, 2009)

 
Other

Cowen Holdings, Inc. 8-K 2009

Documents found in this filing:

  1. 8-K
  2. Ex-10.1
  3. Ex-10.1

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  August 7, 2009

 

COWEN GROUP, INC.

(Exact Name of Registrant as Specified in Charter)

 

Delaware

 

000-52048

 

84-1702964

(State or Other Jurisdiction
of Incorporation

 

(Commission
File Number)

 

(IRS Employer
Identification No.)

 

 

 

 

 

1221 Avenue of the Americas

 

 

New York, New York

 

10020

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code:  (646) 562-1000

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

On August 7, 2009, Christopher A. White, Vice President of Cowen Group, Inc. (the “Company”) entered into a 2009 Carried Interest Award Agreement (the “Agreement”) with the Company.  Under the Agreement, the Company awarded Mr. White the right to receive an amount equal to 0.15387% of the profits, if any, in excess of certain minimum levels (the “Carried Interest”) earned by Cowen Healthcare Royalty GP, LLC as general partner (the “General Partner”) of Cowen Healthcare Royalty Partners, L.P. (the “Fund”) (the “Carried Interest Equivalent Award”).  The Company, as a member of the General Partner, is entitled to receive Carried Interest and had committed to the General Partner upon its formation that the Company would allocate up to 10% of its Carried Interest to certain of the Company’s employees.  Mr. White is one of seventeen Company employees who has received a Carried Interest Equivalent Award in recognition of his or her efforts to support the General Partner and the Fund.  Mr. White serves on the Investment and the Operating Committees, respectively, of the General Partner.  The current estimated potential value of the Carried Interest Equivalent Award is $114,250 over a six year period commencing in 2014.  The Carried Interest Equivalent Award shall vest in two equal installments, with 50% vesting on the second anniversary of the grant date and 50% vesting on the third anniversary of the grant date, subject to Mr. White’s continued employment.  The Agreement is filed as Exhibit 10.1 to this Form 8-K.

 

2



 

Item 9.01. Financial Statements and Exhibits.

 

(d)

 

Exhibit

 

 

 

10.1

 

2009 Carried Interest Award Agreement of Christopher A. White.

 

 

 

 

3



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

COWEN GROUP, INC.

 

 

 

Date: August 10, 2009

By:

/s/ J. Kevin McCarthy

 

 

Name: J. Kevin McCarthy

 

 

Title: General Counsel

 

4


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki